Literature DB >> 7874694

Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon.

R P Bird1.   

Abstract

We previously reported that the colons of animals injected with azoxymethane (AOM) and fed a diet containing cholic acid (CHA) had lower numbers of aberrant crypt foci (ACF) than those in animals fed a control diet. To follow up on this observation, a series of studies was conducted to determine whether CHA affects the development of ACF in a dose- and time-dependent manner, and the possible mechanism(s) involved. Sprague Dawley male rats were injected with AOM (20 mg/kg s.c.), and one week later randomly allocated to groups fed diets containing 0, 0.05, 0.1 or 0.2% CHA by weight, for 4 weeks. Their colons were scored for the number size and location of ACF, number of crypts per ACF, and mitotic activity. It was observed that the number and size of ACF decreased with increasing levels of CHA. Mitotic activity was higher (P < 0.05) in the 0.2% CHA diet (CHA-diet) group compared to the 0% CHA group. To determine if timing of intervention with the CHA-diet was critical, rats were allocated to the CHA-diet before or after AOM injection. The ACF-reducing effect of 0.2% CHA diet was evident (P < or = 0.05) only after AOM injection. Intervention with the CHA-diet 4 weeks after AOM injection demonstrated that the diet eliminated and/or remodelled a large proportion (50%) of ACF which had developed within 4 weeks and inhibited the growth of those ACF that persisted. This effect was also associated with higher (P < or = 0.05) mitotic activity in the colon. Discontinuing the treatment of rats with the CHA-diet resulted in a rapid increase in the number of ACF in their colons, establishing that the growth inhibitory effect of the CHA-diet on ACF was reversible. In conclusion, it was demonstrated that the CHA-diet modulated the number of ACF by inhibiting their development and growth and by eliminating or remodelling a selected population of ACF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7874694     DOI: 10.1016/0304-3835(94)03618-s

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats.

Authors:  Xu-Dong Jia; Chi Han
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Doxorubicin-loaded cholic acid-polyethyleneimine micelles for targeted delivery of antitumor drugs: synthesis, characterization, and evaluation of their in vitro cytotoxicity.

Authors:  Muhammad Wahab Amjad; Mohd Cairul Iqbal Mohd Amin; Haliza Katas; Adeel Masood Butt
Journal:  Nanoscale Res Lett       Date:  2012-12-28       Impact factor: 4.703

3.  Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis.

Authors:  Abdiryim Yusup; Halmurat Upur; Anwar Umar; Benedicte Berke; Dilxat Yimit; Jaya Conser Lapham; Nicholas Moore; Pierrette Cassand
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

4.  A method for serial tissue processing and parallel analysis of aberrant crypt morphology, mucin depletion, and Beta-catenin staining in an experimental model of colon carcinogenesis.

Authors:  John N McGinley; Matthew D Thompson; Henry J Thompson
Journal:  Biol Proced Online       Date:  2010-05-18       Impact factor: 3.244

5.  Ingestion of sugar beet fiber enhances irradiation-induced aberrant crypt foci in the rat colon under an apoptosis-suppressed condition.

Authors:  S Ishizuka; S Ito; M Onuma; T Kasai; Y Aoyama; H Hara
Journal:  Carcinogenesis       Date:  1999-06       Impact factor: 4.944

6.  Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.

Authors:  Y Morishita; N Yoshimi; K Kawabata; K Matsunaga; S Sugie; T Tanaka; H Mori
Journal:  Jpn J Cancer Res       Date:  1997-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.